306 Deputy Richard Bruton asked the Minister for Health and Children if her attention has been drawn to concerns that independent research (details supplied) suggests that patients with osteoporosis experience 50% less improvement in the DXA bone density scan when taking generic alendronate than on branded Fosamax; if this will be taken into account in deciding whether pharmacists can switch from prescribed branded products to generic equivalents under her Departments Generic Substitute initiative. [15022/10]

Summary

306 Deputy Richard Bruton asked the Minister for Health and Children if her attention has been drawn to concerns that independent research (details supplied) suggests that patients with osteoporosis experience 50% less improvement in the DXA bone density scan when taking generic alendronate than on branded Fosamax; if this will be taken into account in deciding whether pharmacists can switch from prescribed branded products to generic equivalents under her Departments Generic Substitute initiative. [15022/10]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Generic Drugs.

  xml · EN · 20 April 2010

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.